MED Earnings

MED reported its earnings on 2026-05-04, showcasing a revenue of 76.04M against an estimate of 73.75M, resulting in a 3.11% surprise. The EPS was -0.19, surpassing the expected -0.55 by 65.45%. The stock experienced a 22.48% price change on the earnings day and a 18.44% change over the next five days, reflecting market reactions to the results.

Following MED's earnings announcement on 2026-05-04, the stock price moved by 22.48% on the day of the release. Over the subsequent five days, it saw a 18.44% change. Historically, MED's stock price tends to shift by an average of -1.45% in the 10 days leading up to earnings and -6.56% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate MED's annual revenue to reach 88.70M, while the EPS is projected at -0.29. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MED's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MED's stock price typically moves by -1.45% in the 10 days before its earnings and -6.56% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.29 and revenue of 88.70M.

The earnings call revealed a significant decline in key financial metrics: revenue, net income, EPS, and cash flow from operations all decreased year-over-year. Additionally, gross profit margin fell, and operating expenses rose. These factors indicate financial challenges and increased costs, leading to a negative sentiment. The absence of strategic initiatives, risk assessment, and return discussions further weakens investor confidence, suggesting a likely negative stock price movement in the short term.